https://think.taylorandfrancis.com/article_collections/journal-of-obstetrics-and-gynaecology-management-of-massive-obstetric-haemorrhage/

Massive obstetric haemorrhage (MOH) remains a leading cause of maternal mortality worldwide, accounting for up to 50% of maternal deaths in some countries and currently constitutes the seventh commonest cause of death in the United Kingdom with a rate of 0.6/100,000 maternities.

Optimum management of this condition require up to date knowledge of relevant treatment modalities (such as Tranexamic Acid and interventional radiology), competent surgical techniques and an appreciation of non-technical skills (i.e. human factors). In particular, decision making and speed of action by the most experienced clinician present (often the registrar) is paramount so that obstetric haemorrhage could be controlled before it deteriorated to coagulopathy and ultimately maternal death.

For this issue, the editors aim to garner a collection of articles to cover the broad aspects pertaining to MOH for the benefit of clinicians and patients alike.

The potential applications encompass a wide spectrum and include, but are not restricted to, the following areas:

  • Human factors in MOH.
  • Cell salvage technology in MOH.
  • Top tips on bedside visual estimation of blood loss.
  • Pelvic packing in PPH: A review of worldwide literature.
  • The role of Interventional Radiology in MOH.
  • The role of Tranexamic Acid in MOH: Review of Evidence
  • Placenta Accreta Spectrum.
  • Management of women who decline blood transfusion.
  • Uterine compression sutures: Which ones should we use?
More Süleyman Cemil Oğlak's questions See All
Similar questions and discussions